Einarsson M, Hggroth L, Mattsson C
Research Department, Kabi, Stockholm, Sweden.
Thromb Haemost. 1989 Dec 29;62(4):1088-93.
The elimination of native and carbohydrate-modified tissue type plasminogen activator (t-PA) after an i.v. bolus injection was studied in rabbits. t-PA with a low content of mannose (man-t-PA) was obtained by treatment with alpha-mannosidase, which cleaves terminal mannose from the carbohydrate side chains of the molecule. About 50% of the total mannose was removed from the native t-PA. Clearance of t-PA in rabbits was followed by measurements of both the fibrinolytic activity of the activators and the radioactivity of the iodine-labelled compounds. A biphasic mode of elimination of the fibrinolytic activity as well as the radioactivity was found with both the native and the carbohydrate modified t-PA. The initial half-life (t 1/2 alpha) was the same, about 1.5 minutes, for both compounds, irrespective of method of analysis. The late half-life (t 1/2 beta) was also the same, about 15 minutes, for both compounds. However, the beta-elimination of native t-PA could only be determined accurately from radioactivity data in the dosages tested, i.e. up to 2 mg of t-PA. No dose dependency in the elimination pattern was observed. In gel filtration experiments, with plasma from the rabbits, it was demonstrated that in addition to fibrinolytically active t-PA and man-t-PA, both fibrinolytically inactive high molecular weight complexes and low molecular weight degradation products of the activators were present in plasma after injection of the compounds. The second phase of elimination (beta) was much more pronounced after mannosidase treatment of the t-PA.(ABSTRACT TRUNCATED AT 250 WORDS)
通过静脉推注给药后,在兔体内研究了天然型和碳水化合物修饰型组织型纤溶酶原激活剂(t-PA)的消除情况。通过用α-甘露糖苷酶处理获得了低甘露糖含量的t-PA(甘露糖-t-PA),该酶从分子的碳水化合物侧链上切割末端甘露糖。从天然t-PA中去除了约50%的总甘露糖。通过测量激活剂的纤溶活性和碘标记化合物的放射性来跟踪兔体内t-PA的清除情况。天然型和碳水化合物修饰型t-PA的纤溶活性以及放射性的消除均呈现双相模式。两种化合物的初始半衰期(t1/2α)相同,约为1.5分钟,与分析方法无关。两种化合物的晚期半衰期(t1/2β)也相同,约为15分钟。然而,仅在测试剂量(即高达2mg的t-PA)下,才能从放射性数据准确确定天然t-PA的β消除情况。在消除模式中未观察到剂量依赖性。在凝胶过滤实验中,使用兔血浆证明,注射化合物后,血浆中除了具有纤溶活性的t-PA和甘露糖-t-PA外,还存在纤溶无活性的高分子量复合物以及激活剂的低分子量降解产物。t-PA经甘露糖苷酶处理后,消除的第二阶段(β)更为明显。(摘要截短于250字)